Literature DB >> 22808295

Atypical squamous cells of undetermined significance in patients with HPV positive DNA testing and correlation with disease progression by age group: an institutional experience.

Erika F Rodriguez1, Jordan P Reynolds, Sarah M Jenkins, Stephanie M Winter, Michael R Henry, Aziza Nassar.   

Abstract

Atypical squamous cells of undetermined significance (ASC-US) is a broad diagnostic category that could be attributed to human papillomavirus infection (HPV), malignant neoplasia and reactive conditions. We evaluated our institutional experience with ASC-US in women who are positive for high risk HPV (HRHPV+) by the Digene hybrid capture method from 2005-2009 to identify the risk of progression to squamous intraepithelial lesion (SIL) and cervical intraepithelial neoplasia (CIN) in association with age. We reviewed cytologic and follow-up surgical pathology reports for all specimens available. Progression was defined as a diagnosis of at least CINI on follow-up biopsy or resection or SIL on cytology. We identified 2613 cases and follow-up was available in 1839 (70.4%). Of these 74.2% had just one follow-up, 16.2% had a total of 2 follow-ups, 5.3% had a total of 3 follow-ups, and the remaining had as many as 6 follow-ups. Among the 1839 patients, 69.4% were age 30 or younger, 16.0% were between 31 to 40, 9.0% were between 41 to 50, and 5.6% were 51 or older. Among these, 25-30% progressed to dysplasia. The risk of progression varied by age (p=0.04) and was lowest among women between the ages of 41-50. Our findings highlight the importance of continued cytologic follow-up in women with HRHPV+ ASC-US in order to detect progression of disease, although the risk of progression is age dependent.

Entities:  

Keywords:  ASC-US; Digene hybrid capture; HPV; Pap smear; cervical cytology

Mesh:

Substances:

Year:  2012        PMID: 22808295      PMCID: PMC3396056     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Visual estimates of nucleus-to-nucleus ratios: can we trust our eyes to use the Bethesda ASCUS and LSIL size criteria?

Authors:  Jared L Schmidt; Jonathan C Henriksen; Dan M McKeon; Kay Savik; H Evin Gulbahce; Stefan E Pambuccian
Journal:  Cancer       Date:  2008-10-25       Impact factor: 6.860

2.  Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.

Authors:  Chengquan Zhao; Shuping Zhao; Amer Heider; R Marshall Austin
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

Review 3.  Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.

Authors:  Donna Dehn; Kathleen C Torkko; Kenneth R Shroyer
Journal:  Cancer       Date:  2007-02-25       Impact factor: 6.860

4.  Smears diagnosed as ASCUS: interobserver variation and follow-up.

Authors:  R M Gatscha; M Abadi; S Babore; D Chhieng; M J Miller; P E Saigo
Journal:  Diagn Cytopathol       Date:  2001-08       Impact factor: 1.582

5.  Diagnosis of "ASCUS" in women over age 50 is less likely to be associated with dysplasia.

Authors:  K Flynn; D L Rimm
Journal:  Diagn Cytopathol       Date:  2001-02       Impact factor: 1.582

6.  Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.

Authors:  Mark F Evans; Christine S-C Adamson; Jacalyn L Papillo; Timothy L St John; Gladwyn Leiman; Kumarasen Cooper
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

Review 7.  The role of human papillomavirus testing in cervical screening.

Authors:  Kate S Cuschieri; Heather A Cubie
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

Review 8.  Atypical squamous cells: update on current concepts.

Authors:  Ritu Nayar; Sana O Tabbara
Journal:  Clin Lab Med       Date:  2003-09       Impact factor: 1.935

9.  Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.

Authors:  Martha Bishop Pitman; Edmund S Cibas; Celeste N Powers; Andrew A Renshaw; William J Frable
Journal:  Cancer       Date:  2002-06-25       Impact factor: 6.860

10.  Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project.

Authors:  Ritu Nayar; Diane Solomon
Journal:  Cytojournal       Date:  2004-10-21       Impact factor: 2.091

View more
  2 in total

1.  Clinicopathologic significance and treatment of ASC-US in cervical cytology.

Authors:  Asrar Mohammed Abdullah Abdulaziz; Lu Liu; Yu Sun; Xuewu You; Baoxia Cui; Sai Han; Youzhong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

2.  Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway.

Authors:  Yan Jiang; Hanjie Xu; Jiafei Wang
Journal:  Oncol Lett       Date:  2016-04-28       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.